- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Effect of Physician-Specific Pay-for-Performance Incentives in a Large Group PracticeThis study examined the effect of physician-specific pay-for-performance incentives on well-established ambulatory quality measures in a large group practice setting.
Latest:
Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient DetoxificationThe mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
Latest:
Breast Cancer Multigene Testing Trends and Impact on Chemotherapy UseA multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Latest:
Medical Home Transformation and Breast Cancer ScreeningBreast cancer screening may not improve in early medical home implementation.
Latest:
Guided Care and the Cost of Complex Healthcare: A Preliminary ReportThe early months of a cluster-randomized trial suggest that Guided Care is associated with a trend toward a net reduction in total healthcare expenditures.
Latest:
Patient Factors Associated With Following a Relocated Primary Care Provider Among Older AdultsThere are differences between patients who elect to maintain continuity with their PCP versus those who choose to change their PCP for convenience.
Latest:
The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality CollaborativeThis article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.
Latest:
Health Information Technology and Physicians' Perceptions of Healthcare QualityHealth information technology can enhance physicians' ability to provide high-quality care, suggesting that physicians should use it more extensively in their practices.
Latest:
Addressing Oncologists' Gaps in the Use of Biosimilar ProductsThe availability of biosimilar products may improve access to healthcare by increasing the number of therapeutic options available at potentially lower costs. As of April 2019, 18 such biological products had been approved by the FDA, including 4 biosimilars for trastuzumab, 3 each for infliximab and adalimumab, 2 each for pegfilgrastim and filgrastim, and 1 each for rituximab, epoetin alfa, bevacizumab, and etanercept. The pace of approvals has accelerated, from the first indication for a filgrastim biosimilar in 2015 to 3 approvals in 2016, 5 in 2017, and 9 through early 2019, 7 of which were announced in the 2018 calendar year.
Latest:
Budget Impact Analysis of 8 Hormonal Contraceptive OptionsA model assessing 8 hormonal contraceptive methods found that lower pregnancy costs for the etonogestrel implant and levonorgestrel intrauterine device offset their higher acquisition costs.
Latest:
Improving the Outcomes of Disease Management by Tailoring Care to the Patient's Level of ActivationTailoring coaching to each patient’s activation level may improve clinical indicators and reduce utilization more than the usual disease management coaching.
Latest:
VHA Pharmacy Use in Veterans With Medicare Drug CoverageGreater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.
Latest:
Accountable Care Organization Initiatives to Improve the Cost and Outcomes of Specialty CareEngaging specialty physicians is an emerging area of focus for Medicare accountable care organizations. Enhanced data on specialist costs and outcomes are essential to addressing alignment challenges.
Latest:
Changing Trends in Type 2 Diabetes Mellitus Treatment Intensification, 2002-2010Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.
Latest:
The Effect of a Cardiovascular Educational Intervention on Healthcare Utilization and CostsA low-cost cardiovascular disease screening and periodic educational intervention did not increase healthcare resource utilization and expenditures at 1 year.
Latest:
Retail Clinic Versus Office Setting: Do Patients Choose Appropriate Providers?Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.
Latest:
Caregiver Presence and Patient Completion of a Transitional Care InterventionCaregivers' presence during patient recruitment is associated with a greater rate of completion of a post hospital transitional care coaching intervention, particularly among men.
Latest:
Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?Data from mHealth can inform, assess, anticipate, and aid in interventions while monitoring and coordinating patient health status and care.
